VEGF Contributes to Mesenchymal Stem Cell-Mediated Reversion of Nor1-Dependent Hypertrophy in iPS Cell-Derived Cardiomyocytes

Myocardial hypertrophy is present in many heart diseases, representing a strong predictor of adverse cardiovascular outcomes. Regarding therapeutic intervention, mesenchymal stem cells (MSCs) have been suggested to significantly reduce cardiac hypertrophy and progression to heart failure. Preconditi...

Descripción completa

Detalles Bibliográficos
Autores principales: Philipp, Denise, Holthaus, Michelle, Basoah, Vida, Pfannkuche, Kurt, Suhr, Laura, Wahlers, Thorsten, Paunel-Görgülü, Adnana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053052/
https://www.ncbi.nlm.nih.gov/pubmed/33927770
http://dx.doi.org/10.1155/2021/8888575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053052/
https://www.ncbi.nlm.nih.gov/pubmed/33927770
http://dx.doi.org/10.1155/2021/8888575

Ejemplares similares